Clinical associations with thyroid disease in ANCA-associated vasculitis
Clinical Rheumatology · 2024
DOI: 10.1007/s10067-024-07146-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Rheumatology, 2024. Verfasst von Zhihuan Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, The Second Affiliated Hospital of Chongqing Medical University, 74 Linjiang Road, Yuzhong District, Chongq…. Hauptthemen laut MEDLINE: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Thyroid Diseases. Die Arbeit nennt 29 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, Chongqing Talents Program, Program for Youth Innovation in Future Medicine of Chongqing Medical University.
Abstract (Originalsprache)
OBJECTIVE: To evaluate the frequency and the clinical relevance of thyroid disease in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) patients. METHODS: A total of 305 AAV patients admitted to the Second Affiliated Hospital of Chongqing Medical University between October 2010 and December 2023 were analyzed. Demographic, clinical, and laboratory data were compared between AAV patients with and without thyroid disease. Univariate and multivariate logistic regression analyses were conducted to identify factors associated with thyroid disease in AAV patients. RESULTS: Among the 305 AAV patients, 52 (17.0%) had concurrent thyroid disease. In univariate analysis, gender, coronary artery disease, renal involvement, anti-Ro/SSA antibodies, anti-Ro52 antibodies, anti-thyroglobulin antibodies (TgAb), and anti-thyroid peroxidase antibodies (TPOAb) exhibited significant differences between AAV patients with and without thyroid disease (P < 0.05). Multivariate analysis revealed that female gender (odds ratio (OR) = 2.423, 95% confidence interval (95% CI) 1.241, 4.729; P = 0.009), concurrent coronary artery disease (OR = 2.998, 95% CI 1.280, 7.019; P = 0.011), and positive anti-Ro/SSA antibodies (OR = 4.697, 95% CI 1.960, 11.257; P = 0.001) were associated with thyroid disease in AAV patients. CONCLUSION: AAV patients have a higher incidence of thyroid disease. Regular monitoring of thyroid function is advised for AAV patients, particularly for women, those with coronary artery disease, and those who are positive for anti-Ro/SSA antibodies. Key Points • AAV patients have a higher incidence of thyroid disease. • The potential clinical relevance of AAV patients with thyroid disease was explored. • Regular monitoring of thyroid function is advised for AAV patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, The Second Affiliated Hospital of Chongqing Medical University, 74 Linjiang Road, Yuzhong District, Chongqing, 400010, China.
- Department of Rheumatology and Immunology, The Second Affiliated Hospital of Chongqing Medical University, 74 Linjiang Road, Yuzhong District, Chongqing, 400010, China. hopetang@hospital.cqmu.edu.cn.
Förderung
- the National Natural Science Foundation of China
- Chongqing Talents Program
- Program for Youth Innovation in Future Medicine of Chongqing Medical University
- the Kuanren Talents Program of the Second Affiliated Hospital of Chongqing Medical University
Zitieren
APA
Zhang, Z., Huang, W., Ren, F., Luo, L., Zhou, J., Huang, D., Chen, D., Qian, K., Wang, Y., & Tang, L. (2024). Clinical associations with thyroid disease in ANCA-associated vasculitis. Clinical Rheumatology. https://doi.org/10.1007/s10067-024-07146-5
Vancouver
Zhang Z, Huang W, Ren F, Luo L, Zhou J, Huang D, et al. Clinical associations with thyroid disease in ANCA-associated vasculitis. Clinical Rheumatology. 2024. doi:10.1007/s10067-024-07146-5
BibTeX
@article{Zhang2024,
author = {Zhang, Zhihuan and Huang, Wenhan and Ren, Feifeng and Luo, Lei and Zhou, Jun and Huang, Dongmei and Chen, Dandan and Qian, Kechen and Wang, Yuanyuan and Tang, Lin},
title = {Clinical associations with thyroid disease in ANCA-associated vasculitis},
journal = {Clinical Rheumatology},
year = {2024},
doi = {10.1007/s10067-024-07146-5}
}
EUVIMED